Ascendis Pharma wins FDA approval for navepegritide for achondroplasia
Ascendis Pharma A/S Ordinary Share · Now $218.82
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS